Home » Archive

Xconomy

Drug Development, News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Isis, Neurocrine, MEI, and More

Posted by sandiegobiotech September 12th, 2013 .
No Comments

Isis Pharmaceuticals extended its reach in neurological drugs this week by signing its fourth collaboration agreement with Biogen Idec. We have that and the rest of San Diego’s life sciences news…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

5 Things Biotechs Should Do to Take Advantage of The Boom

Posted by sandiegobiotech September 5th, 2013 .
No Comments

We are currently enjoying a much needed resurgence in the biotechnology industry. The industry has been the best performing sector in the stock market for the last two years and it appears it will be…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Biotech and Fantasy Football Picks for Fall 2013

Posted by sandiegobiotech September 3rd, 2013 .
No Comments

There’s an old saying about surgeons. They are “sometimes wrong; never in doubt.” If only the same could be said for biotech writers. I’ve been sometimes right, sometimes wrong, and sometimes…

[[Click headline to continue reading.]]

More...

Events, News, Syndication, Xconomy »

Announcing Oct. 15 Xconomy Healthcare Summit: Request An Invitation

Posted by sandiegobiotech August 28th, 2013 .
No Comments

There’s hardly an issue that is more of a hot button than healthcare—and there’s hardly an issue that is surrounded by as much poorly understood, misguided, or outright misleading information. Yet…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Why Good Drugs Sometimes Fail: The Bexxar Story

Posted by sandiegobiotech August 26th, 2013 .
No Comments

Quite a few biotech entrepreneurs go to work each day operating under the assumption that clinical trial data is king. If you put together a rock-solid dataset from a big clinical trial that says…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Applied Proteomics Snags $28M to Look for Disease Markers in Blood

Posted by sandiegobiotech August 21st, 2013 .
No Comments

San Diego’s Applied Proteomics, founded in 2007 to automate the process of accurately measuring all the protein fragments in a drop of blood, has raised $28 million in a Series C round of financing….

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Sequenom Discloses 75 Layoffs as Part of Cost-Cutting Reorganization

Posted by sandiegobiotech August 19th, 2013 .
No Comments

San Diego-based Sequenom (NASDAQ: SQNM), which specializes in molecular diagnostics and genetic analysis, plans to lay off 75 employees, or nearly 13 percent of its workforce, as part of a…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Technology to Assess Neurons Gives New Life to San Diego’s Afraxis

Posted by sandiegobiotech August 19th, 2013 .
No Comments

San Diego’s Afraxis, which ceased to exist in January after the neuroscience startup licensed its entire library of drug compounds to Roche’s Genentech, has sprung back to life with proprietary…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Who Should Biotech Pros Follow on Twitter? An Update for 2013

Posted by sandiegobiotech August 19th, 2013 .
No Comments

[Updated: 12:07 pm PT] Twitter is where the biotech industry comes to trade news, analysis, and gossip every day. This has been true for a couple years. The 140-character blogging platform just keeps…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Fate Therapeutics Joins Biotech IPO Conga Line, Reaching for $69M

Posted by sandiegobiotech August 14th, 2013 .
No Comments

San Diego-based Fate Therapeutics, the company that made a big splash a few years ago when it rounded up some big-name scientists with aspirations to do big things with stem cells, is the latest…

[[Click headline to continue reading.]]

More...